Detalhe da pesquisa
1.
Impairment of health-related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL Consortium.
Pediatr Blood Cancer
; 70(11): e30560, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37461125
2.
Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana-Farber Cancer Institute ALL Consortium trial 05-001.
Pediatr Blood Cancer
; 69(8): e29581, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35316569
3.
Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001.
Pediatr Blood Cancer
; 68(1): e28719, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33026184
4.
Influence of BCL2L11 polymorphism on osteonecrosis during treatment of childhood acute lymphoblastic leukemia.
Pharmacogenomics J
; 19(1): 33-41, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29282361
5.
Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations.
Am J Hematol
; 93(11): 1358-1367, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30117174
6.
Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 65(7): e27062, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29603593
7.
An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001.
Pediatr Blood Cancer
; 65(3)2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29090520
8.
Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001.
Pediatr Blood Cancer
; 65(10): e27256, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29878490
9.
The use of prophylactic anticoagulation during induction and consolidation chemotherapy in adults with acute lymphoblastic leukemia.
J Thromb Thrombolysis
; 45(2): 306-314, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29260426
10.
Cardiovascular disease in adult survivors of childhood cancer.
Annu Rev Med
; 66: 161-76, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25587648
11.
A thymidylate synthase polymorphism is associated with increased risk for bone toxicity among children treated for acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 64(7)2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27957785
12.
Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin-treated childhood acute lymphoblastic leukemia survivors.
Cancer
; 122(6): 946-53, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26762648
13.
Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck.
Cancer
; 122(23): 3632-3640, 2016 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27509377
14.
c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells.
Blood
; 123(7): 1040-50, 2014 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24394663
15.
Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission.
Am J Hematol
; 91(3): 322-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26701142
16.
Corrigendum.
Pediatr Blood Cancer
; 68(3): e28885, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33506554
17.
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
Lancet Oncol
; 16(16): 1677-90, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26549586
18.
Targeting oncogenic interleukin-7 receptor signalling with N-acetylcysteine in T cell acute lymphoblastic leukaemia.
Br J Haematol
; 168(2): 230-8, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25256574
19.
Therapeutic approaches to haematological malignancies in adolescents and young adults.
Br J Haematol
; 164(1): 3-14, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24007213
20.
Impact of promoter polymorphisms in key regulators of the intrinsic apoptosis pathway on the outcome of childhood acute lymphoblastic leukemia.
Haematologica
; 99(2): 314-21, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24038028